Rock Springs Capital Management LP Vertex Pharmaceuticals Inc Transaction History

Rock Springs Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $1.86 Million - $2.48 Million	-9,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $29.7 Million - $35.2 Million	-116,000 Reduced 92.8%	9,000 $2.45 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $15.6 Million - $19.3 Million	-78,000 Reduced 38.42%	125,000 $29.7 Million
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $1.06 Million - $1.35 Million	7,000 Added 3.57%	203,000 $33.6 Million
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $922,515 - $1.06 Million	5,500 Added 2.89%	196,000 $37.8 Million
Q2 2018 Aug 14, 2018	BUY	$145.72 - $169.96 $1.38 Million - $1.61 Million	9,500 Added 5.25%	190,500 $32.4 Million
Q1 2018 May 15, 2018	BUY	$151.6 - $177.13 $1.48 Million - $1.73 Million	9,750 Added 5.69%	181,000 $29.5 Million
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $2.71 Million - $3.07 Million	19,750 Added 13.04%	171,250 $25.7 Million
Q3 2017 Nov 14, 2017	BUY	$148.13 - $162.24 $22.4 Million - $24.6 Million	151,500	151,500 $23 Million

1,716

225M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Rock Springs Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Rock Springs Capital Management LP with notifications on news.